The Meaning Behind Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:
- Leafly Holdings LFLY - P/E: 0.58
- Zymeworks ZYME - P/E: 2.89
- Kiniksa Pharmaceuticals KNSA - P/E: 5.61
- Dynavax Technologies DVAX - P/E: 9.1
- Aptevo Therapeutics APVO - P/E: 0.33
This quarter, Leafly Holdings experienced an increase in earnings per share, which was $-0.17 in Q4 and is now $-0.14. Zymeworks has reported Q1 earnings per share at $-0.34, which has decreased by 107.22% compared to Q4, which was 4.71. Most recently, Kiniksa Pharmaceuticals reported earnings per share at $-0.18, whereas in Q4 earnings per share sat at $0.06. Most recently, Dynavax Technologies reported earnings per share at $-0.19, whereas in Q4 earnings per share sat at $0.45. Aptevo Therapeutics has reported Q1 earnings per share at $-0.98, which has increased by 31.94% compared to Q4, which was -1.44.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.